IRST Adoptive CAR T Cell Platform
Company intelligence

IRST Adoptive CAR T Cell Platform Company Intelligence, Company Record Signals

Social audience
38
Audience size from company social follower data.
Audience density
Low audience density
38 followers against 6 employee estimate, about 6.30 followers per estimated employee.
Market focus
16 signals
16 market classification signals across categories, specialties, and related peer industries.
Related peer graph
10
Related peer graph has industry context, employee benchmarks, website records, and social profiles across 10 related companies.

AeroLeads company intelligence

IRST Adoptive CAR T Cell Platform company signal intelligence

Evidence from AeroLeads company records and related company graph.

Medium confidence
Intelligence completeness
Basic intelligence record
2 of 11 major intelligence groups are available for this company.
Social followers
38
Audience size from company social data.

Data methodology

AeroLeads renders only source-backed fields for this company page.

3 source groups
Company record Related company graph Company signal fields
Blank source fields are omitted
Related companies are ordered deterministically
Structured data uses aggregate counts only

Intelligence completeness

2 of 11 major intelligence groups are available for this company.

2 / 11 groups
Basic intelligence record 18.2%
Domain confidence Market and peer context

Domain trust signals

Domain confidence for irst.emr.it is based on website domain and social profile.

35 / 100
Basic domain identity Limited domain evidence

Domain evidence combines website domain and social profile; raw email addresses are hidden.

Website domain
irst.emr.it
The official website domain is available from the company source record.
Social profile
LinkedIn organization page
A LinkedIn organization page is present for this company record.

AeroLeads coverage snapshot

Domain confidence
Basic domain identity
Domain confidence for irst.emr.it is based on website domain and social profile.
Company signal breadth
Multi-signal company record
Company-level signals include social audience, company maturity, and ownership.
Company ownership signal
Nonprofit organization record
Company source record includes source type Nonprofit.
Audience density
Low audience density
38 followers against 6 employee estimate, about 6.30 followers per estimated employee.
Specialty signals
10
Specialty tags in the company record.
Market specificity
Focused market profile
16 market classification signals across categories, specialties, and related peer industries.
Peer industry clusters
7
Industries represented by related company records.
Related companies
10
Company graph links available for comparison.
Industry benchmark
Evidence-backed industry benchmark
Industry benchmark uses 10 related companies, 2 same-industry peers, 3 benchmark dimensions, and 4 peer evidence types from the AeroLeads related-company graph.
Peer benchmark confidence
Multi-signal peer benchmark evidence
Peer benchmark combines 10 related companies with peer graph strength, size benchmark, and size position. Underlying peer graph includes 4 evidence types: industry context, employee benchmarks, website records, social profiles.
Peer position benchmark
Employee-scale peer position benchmark
Peer-position benchmark shows employee scale above 20% of 10 comparable related peers.
Peer comparison matrix
Limited peer comparison
Compares this company with related-company evidence across employee scale and peer graph evidence.
Intelligence signal groups
3
AeroLeads signal groups available for this company.

Market focus signals

Primary industry
Hospitals and Health Care
Market specificity
Focused market profile
16 market classification signals across categories, specialties, and related peer industries.
Market evidence tier
High-confidence market evidence
Market evidence combines 16 classification signals from categories, specialties, related peer industries, and description keywords. 6 description-backed keyword signals are included.
Industry benchmark
Evidence-backed industry benchmark
Industry benchmark uses 10 related companies, 2 same-industry peers, 3 benchmark dimensions, and 4 peer evidence types from the AeroLeads related-company graph.
Top peer industry
Hospitals and Health Care
20% of 10 related peer industry signals.
Peer benchmark evidence
Multi-signal peer benchmark evidence
Peer benchmark combines 10 related companies with peer graph strength, size benchmark, and size position. Underlying peer graph includes 4 evidence types: industry context, employee benchmarks, website records, social profiles.
Size position
Smaller than most related peers
8 of 10 related employee-estimated peers are higher.
Peer graph strength
Benchmark-ready peer graph
Related peer graph has industry context, employee benchmarks, website records, and social profiles across 10 related companies.
Benchmark dimensions: peer graph strength, size benchmark, and size position.
Categories
Hospitals and Health Care
Specialties
Oncology Immunotherapy Molecular immunology CAR TCR Phage display Early diagnosis biomarkers MPM
Product-market keyword evidence
Description-backed market keywords
Keyword evidence comes from 3 source field groups: Category, Specialty, Description.
Product-market keyword evidence tier: High-confidence product-market keyword evidence. Product-market keyword evidence combines 17 unique market keywords, 3 source field groups, and 6 description-backed keywords (1 category, 10 specialty, and 6 description).
Hospitals and Health Care · Category Oncology · Specialty Immunotherapy · Specialty Molecular immunology · Specialty CAR · Specialty TCR · Specialty Phage display · Specialty Early diagnosis biomarkers · Specialty MPM · Specialty Multiple Myeloma · Specialty T-ALL · Specialty research activity · Description
Related peer industries
Peer-industry evidence tier: High-confidence peer-industry evidence. Peer-industry evidence combines 10 related companies, 5 peer-industry clusters, and top peer industry Hospitals and Health Care at 20.0%.
Hospitals and Health Care 2 peers
20.0% of related peer industries
Research 2 peers
20.0% of related peer industries
Research Services 2 peers
20.0% of related peer industries
Non-profit Organizations 1 peer
10.0% of related peer industries
Wellness and Fitness Services 1 peer
10.0% of related peer industries

Company signals

Company signal breadth
Multi-signal company record
Company-level signals include social audience, company maturity, and ownership.
Corroborated company record evidence: Company record evidence combines 3 source-backed company signal types: social audience, company maturity, and ownership.
Social audience
38
Followers in the company source record.
Social audience evidence tier: Limited social-audience evidence. Social audience evidence uses 38 followers from source field social_followers.
Audience density
Low audience density
38 followers against 6 employee estimate, about 6.30 followers per estimated employee.
Audience-density evidence tier: Limited audience-density evidence. Audience-density evidence combines 38 social followers, 6 employee estimate, and 6.30 followers per estimated employee.
Company maturity
Emerging company history
Company source record includes founding year 2020, about 6 years before 2026.
Company maturity evidence tier: Founding-year maturity evidence. Maturity evidence combines founding year 2020, 6 years of company history, and source field founded.
Company ownership
Nonprofit organization record
Company source record includes source type Nonprofit.
Company ownership evidence tier: Structured ownership evidence. Ownership evidence combines source type Nonprofit from structured company source fields.

Explore related pages

Related company intelligence:

IRST Adoptive CAR T cell platform focuses its research activity on understanding, characterizing, exploiting and modifying the human adaptive immune response to control and fight human neoplasms (mesothelioma, NET, NSCLC, MM, T-ALL). Our projects take advantage of very advanced technologies available at the IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" and revolve around molecular immunology and immunotherapy. We perform screenings for novel specificities in human tumors via BCR repertoire analyses to identify human targeting antibodies from patients and by phage display technology. Antibody sequences are then used to design CAR constructs to genetically engineer human immune cells and modify their tropism towards tumors. While CAR T cells target antigens physiologically or unappropriately residing at the cell surface, TCRs can intercept neoantigens expressed inside cells and presented on MHC / HLA molecules thereby providing novel opportunities for the development of antitumor immunotherapies. Via TCR repertoire analyses coupled to in vitro biological assays we aim to identify TCRs able to recognize with high affinity tumor associated neoantigens. The Adoptive CAR T cell platform can leverage on both in vitro and in vivo preclinical models to test the activity and specificity of most promising CAR and TCR receptors. We use and develop lenti/retroviral based constructs and CRISPR/Cas9 editing approaches to modify also other biological properties of the cells to promote persistence and efficacy further or to couple immunotherapy with radiotherapy (radiocell theranostics). The platform is also involved in the study of the human adaptive immune response to experimental vaccines via serological and TCR repertoire analyses. With the aim of producing allogeneic ATMPs the platform collaborate with an European international consortium which has isolated, produced and characterize iPSCs to implement academic gene therapy based approaches in EU.

Company source details

Founded
2020
Address
Meldola, Forlì-cesena, IT
Industry
Hospitals And Health Care
NAICS
Health Care and Social Assistance
Social Assistance
Website
www.irst.emr.it
Keywords
Oncology, Immunotherapy, Molecular immunology, CAR, TCR, Phage display, Early diagnosis biomarkers, MPM, Multiple Myeloma, T-ALL, Melanoma, NSCLC, NET, Neuroendocrine tumors, Theranostics, Gene therapy, iPSC, CRISPR/Cas9, Preclinical development, Therapeutic vaccines.
HQ
Meldola, FC
Related companies
Hospital Clínic de Barcelona, Fundació Clínic per a la Recerca Biomèdica, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST Srl, Istituto Oncologico Romagnolo, Sociedad Española de Hematología y Hemoterapia (SEHH), Cellab - CDMO, Institute of Geoenergy (FORTH/IG), CHR Partners, T-FITNESS, TwInn4MicroUp Project.

IRST Adoptive CAR T Cell Platform Questions